Last quarterly 4C shows IBX have over a year worth of funding remaining, plenty of funding to allow completion of the current phase 1 trial.
Expect significant uplift in market cap upon confirmation of this phase, which recent report suggests, which would mean any capital raise (if not via alternative capital pathways) will be at significantly higher share price.
I don't see the need to scaremonger at this stage.
Last quarterly 4C shows IBX have over a year worth of funding...
-
- There are more pages in this discussion • 504 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
